Gary Stibel

Gary Stibel

Opinion author

Gary Stibel is the founder, CEO, and managing partner of the New England Consulting Group. With over half a century of experience, Gary has worked in nearly every segment of the healthcare and life sciences industries, addressing a wide range of disease states and playing a pivotal role in numerous major innovations, from OTC and VMHS to pharmaceuticals and medical devices.

Novo Nordisk’s GLP-1s outsell Eli Lilly’s thanks to its superior marketing. Here’s how.